Biopharma’s AI revolution is about more than algorithms
Press & NewsRead now on Fierce Pharma. Artificial intelligence (AI) has enormous potential in healthcare, but all too often, it gets misunderstood.
Dec 18, 2023
How can AI and care coordination can help overcome diagnostic challenges in Cardiac Amyloidosis?
Start a conversation with Viz.aiAI-powered care coordination offers hope in overcoming the challenges associated with Cardiac Amyloidosis diagnosis. Trained on vast datasets of ECG and echocardiogram tests, AI algorithms can detect subtle patterns indicative of Cardiac Amyloidosis, facilitating early diagnosis even before significant symptoms appear. By capturing cues imperceptible to the human eye at earlier stages of the disease, AI-powered care coordination prompts clinicians to determine the next best action. Appropriate workup and treatment is a critical step in preventing disease progression and improving patient outcomes.
Equipped with FDA-cleared algorithms, integrated imaging viewers for ECG, echo, and MRI, seamless EHR integration, and robust care team communication tools, the Viz Cardio Suite provides a comprehensive solution for streamlined cardiac disease management.
HCPs review patients with ECGs with suspected ATTR-CM findings, highlighted in green
HCPs gain access to multiple ECGs for patients flagged with suspected ATTR-CM
HCPs seamlessly navigate echocardiograms alongside ECGs for a comprehensive diagnostic overview
Trusted by
1600+
hospitals with users across many specialties and disease areas
Screening 1 patient every
10
seconds
>90%
of alerts viewed within 5 minutes
Backed by robust clinical evidence with
100+
publications and abstracts
Schedule a meeting
Experience the power of AI
See for yourself how you can harness the power of AI to accelerate patient access to care through AI-powered care coordination.